Harnessing nanoengineered CAR-T cell strategies to advance solid tumor immunotherapy
Trends in Cell Biology · 2025-09 · 35 (9) · 782-798
DOI: 10.1016/j.tcb.2024.11.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cell Biology, 2025-09. Verfasst von Xiaoxiao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China; West…. Hauptthemen laut MEDLINE: Neoplasms, Receptors, Chimeric Antigen, Nanotechnology, Immunotherapy, Adoptive. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
The efficacy and safety of chimeric antigen receptor (CAR) T cell therapy is still inconclusive in solid tumor treatment. Recently, nanotechnology has emerged as a potent strategy to reshape CAR-T cell therapy with promising outcomes. This review aims to discuss the significant potential of nano-engineered CAR-T cell therapy in addressing existing challenges, including CAR-T cell engineering evolution, tumor microenvironment (TME) modulation, and precise CAR-T cell therapy (precise targeting, monitoring, and activation), under the main consideration of clinical translation. It also focuses on the growing trend of technological convergence within this domain, such as mRNA therapeutics, organoids, neoantigen, and artificial intelligence. Moreover, safety management of nanomedicine is seriously emphasized to facilitate clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China; West China School of Stomatology, Sichuan University, Chengdu 610041, Sich…
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Radiation Oncology, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Radiation Oncology, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: zoubingwen81@163.com.
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: guogang@scu.edu.cn.
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Project
- Natural Science Foundation of Sichuan Province
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Wang, X., Fan, R., Mu, M., Zhou, L., Zou, B., Tong, A., & Guo, G. (2025). Harnessing nanoengineered CAR-T cell strategies to advance solid tumor immunotherapy. Trends in Cell Biology, 35(9), 782-798. https://doi.org/10.1016/j.tcb.2024.11.010
Vancouver
Wang X, Fan R, Mu M, Zhou L, Zou B, Tong A, et al. Harnessing nanoengineered CAR-T cell strategies to advance solid tumor immunotherapy. Trends in Cell Biology. 2025;35(9):782-798. doi:10.1016/j.tcb.2024.11.010
BibTeX
@article{Wang2025,
author = {Wang, Xiaoxiao and Fan, Rangrang and Mu, Min and Zhou, Liangxue and Zou, Bingwen and Tong, Aiping and Guo, Gang},
title = {Harnessing nanoengineered CAR-T cell strategies to advance solid tumor immunotherapy},
journal = {Trends in Cell Biology},
year = {2025},
volume = {35},
number = {9},
pages = {782--798},
doi = {10.1016/j.tcb.2024.11.010}
}
EUVIMED